69 related articles for article (PubMed ID: 9715949)
1. Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis.
Ito A; Plancarte A; Ma L; Kong Y; Flisser A; Cho SY; Liu YH; Kamhawi S; Lightowlers MW; Schantz PM
Am J Trop Med Hyg; 1998 Aug; 59(2):291-4. PubMed ID: 9715949
[TBL] [Abstract][Full Text] [Related]
2. Serodiagnosis of human neurocysticercosis using antigenic components of Taenia solium metacestodes derived from the unbound fraction from jacalin affinity chromatography.
Machado GA; Oliveira HB; Gennari-Cardoso ML; Mineo JR; Costa-Cruz JM
Mem Inst Oswaldo Cruz; 2013 May; 108(3):368-75. PubMed ID: 23778661
[TBL] [Abstract][Full Text] [Related]
3. Multiantigen print immunoassay (MAPIA) for the diagnosis of neurocysticercosis: a single-center diagnostic optimization and accuracy study in Lima, Peru.
Toribio L; Guzman C; Noazin S; Zimic-Sheen A; Zimic M; Gonzales I; Saavedra H; Pretell EJ; Bustos JA; Handali S; García HH;
J Clin Microbiol; 2023 Dec; 61(12):e0076023. PubMed ID: 37966225
[TBL] [Abstract][Full Text] [Related]
4. Are alternative sources of parasitic (cysticercal) antigens necessary for diagnosis of neurocysticercosis?
Katti MK
J Clin Microbiol; 2000 Sep; 38(9):3524-5. PubMed ID: 11203335
[No Abstract] [Full Text] [Related]
5. Serological and molecular detection of neurocysticercosis among epileptic patients in Nagpur, Maharashtra state (India).
Satyaprakash K; Khan WA; Zade NN; Chaudhari SP; Shinde SV; Kurkure NV; Shembalkar PK
Helminthologia; 2023 Sep; 60(3):208-220. PubMed ID: 38152476
[TBL] [Abstract][Full Text] [Related]
6. Serological surveillance of parasitic zoonoses in 13 highlands regions of Peru: Period 2016-2019.
Antitupa I; Vargas-Mayuri NJ; Mayo JV; Estares-Porras LA; Quispe Paredes WM; Sánchez EL; Solis-Sánchez G
Rev Peru Med Exp Salud Publica; 2023; 40(2):189-199. PubMed ID: 38232265
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of an immunochromatography-based point-of-care test kit for a rapid diagnosis of human cysticercosis.
Sadaow L; Boonroumkaew P; Rodpai R; Janwan P; Sanpool O; Thanchomnang T; Morishima Y; Sato MO; Sako Y; Kobayashi K; Iwai M; Maleewong W; Yamasaki H; Intapan PM
Food Waterborne Parasitol; 2023 Dec; 33():e00211. PubMed ID: 37868190
[TBL] [Abstract][Full Text] [Related]
8. Rising trends of neurocysticercosis: A serological report from tertiary-care hospital in South India.
Thamilselvan P; Muthuraman KR; Mandal J; Parija SC
Trop Parasitol; 2016; 6(2):141-146. PubMed ID: 27722103
[TBL] [Abstract][Full Text] [Related]
9. Experimental brain infection with cysticercosis in sheep.
Sota KA; Bustos JA; Verastegui MR; Toribio L; Chile N; Angulo N; Cangalaya C; Calcina J; González AE; Gilman RH; García HH
Rev Peru Med Exp Salud Publica; 2022; 39(3):328-335. PubMed ID: 36478166
[TBL] [Abstract][Full Text] [Related]
10. Consistent Measurement of Parasite-Specific Antigen Levels in Sera of Patients with Neurocysticercosis Using Two Different Monoclonal Antibody (mAb)-Based Enzyme-Linked Immunosorbent Assays.
Castillo Y; Toribio LM; Guzman C; Arroyo G; Espinoza C; Saavedra H; Bustos JA; Dorny P; O'Neal SE; Garcia HH;
Pathogens; 2023 Apr; 12(4):. PubMed ID: 37111451
[TBL] [Abstract][Full Text] [Related]
11. Recognition of immune reactive proteins as a potential multiepitope vaccine candidate of Taenia solium cysticerci through proteomic approach.
Kaur R; Arora N; Rawat SS; Keshri AK; Singh G; Kumar R; Prasad A
J Cell Biochem; 2023 Oct; 124(10):1587-1602. PubMed ID: 37697970
[TBL] [Abstract][Full Text] [Related]
12. Neurocysticercosis in Epileptic Children: An Overlooked Condition in Mozambique, Challenges in Diagnosis, Management and Research Priorities.
Noormahomed EV; Nhancupe N; Mufume J; Schooley RT; Foyaca-Sibat H; Benson CA
EC Microbiol; 2021 Jul; 17(6):49-56. PubMed ID: 37441580
[TBL] [Abstract][Full Text] [Related]
13. Demographics and Clinical Characteristics of Patients with Neurocysticercosis: A Retrospective Study from Dali, China.
Zhu HX; Li YC; Yang XP; Chu YH; Guo W; Chen RX; Guo DD; Cheng LJ; Li Y
Saudi J Med Med Sci; 2023; 11(4):283-291. PubMed ID: 37970452
[TBL] [Abstract][Full Text] [Related]
14. Neurocysticercosis Diagnosis in a Non-Endemic Country: France.
Zemmour I; Durieux MF; Herault E; Rouges C; Šoba B; Mercier A; Ariey F; Preux PM; Yera H; On Behalf Of Collaborators Group
Pathogens; 2023 Sep; 12(10):. PubMed ID: 37887721
[TBL] [Abstract][Full Text] [Related]
15. Neurocysticercosis mimicking craniopharyngioma: A case report.
Rehman AF; Lazo-Vasquez AF; Bhatt PK; Quiroz T; Joseph JA; Gultekin S; Montreuil N; Sternberg CA; Ayoade F
Clin Case Rep; 2023 Dec; 11(12):e8166. PubMed ID: 38046801
[TBL] [Abstract][Full Text] [Related]
16. Oxfendazole Nitazoxanide combination in experimental neurocysticercosis - Anti-inflammatory and cysticidal effects.
Araújo JAA; Gomes TC; Lima VCN; Silva YBD; Lino Junior RS; Vinaud MC
Exp Parasitol; 2024 Apr; 262():108764. PubMed ID: 38677580
[TBL] [Abstract][Full Text] [Related]
17. Worm in the Eye: A Case Report of Ocular Neurocysticercosis With Adherent Retinal Cyst.
Rama K; Jahagirdar V; Ginnaram ARR; Pottabathini R; Mandapalli V
Cureus; 2023 Dec; 15(12):e50194. PubMed ID: 38186517
[TBL] [Abstract][Full Text] [Related]
18. Concomitant multiple subretinal cysticerci in neurocysticercosis.
Chhabra S; Narang S; Bhattacharyya A; Kaur R
Trop Parasitol; 2023; 13(1):65-67. PubMed ID: 37415752
[TBL] [Abstract][Full Text] [Related]
19. Urine 1H-NMR Metabolomics to Discriminate Neurocysticercosis Patients from Healthy Controls: An Exploratory Study.
Lopez JM; Leyva VE; Bustos JA; Perez E; Sanchez S; Saavedra H; Gonzales I; Maruenda H; Garcia HH;
Am J Trop Med Hyg; 2022 May; 107(1):143-5. PubMed ID: 35605633
[TBL] [Abstract][Full Text] [Related]
20. A study on neurcognitive disorders and demographic profile of neurocysticercosis patients.
Goyal G; Kaur U; Lal V; Mahesh KV; Sehgal R
Trop Parasitol; 2021; 11(2):108-112. PubMed ID: 34765532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
